<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">9702341</journal-id>
<journal-id journal-id-type="pubmed-jr-id">22136</journal-id>
<journal-id journal-id-type="nlm-ta">J Neural Transm (Vienna)</journal-id>
<journal-id journal-id-type="iso-abbrev">J Neural Transm (Vienna)</journal-id>
<journal-title-group>
<journal-title>Journal of neural transmission (Vienna, Austria : 1996)</journal-title>
</journal-title-group>
<issn pub-type="ppub">0300-9564</issn>
<issn pub-type="epub">1435-1463</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">29127484</article-id>
<article-id pub-id-type="pmc">5826848</article-id>
<article-id pub-id-type="doi">10.1007/s00702-017-1803-y</article-id>
<article-id pub-id-type="manuscript">NIHMS919569</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Progress in Developing Transgenic Monkey Model for Huntington’s Disease</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Snyder</surname>
<given-names>Brooke R.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="author-notes" rid="FN1">*</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Chan</surname>
<given-names>Anthony W.S.</given-names>
</name>
<xref ref-type="aff" rid="A2">2</xref>
<xref ref-type="author-notes" rid="FN1">*</xref>
</contrib>
</contrib-group>
<aff id="A1">
<label>1</label>Biology Department, Jefferson State Community College, 2601 Carson Road, Birmingham, AL 35215</aff>
<aff id="A2">
<label>2</label>Department of Human Genetics, Emory University School of Medicine and Division of Neuropharmacology and Neurologic Diseases, Yerkes National Primate, Research Center, Transgenic Huntington’s Disease Monkey Resource, 954 Gatewood, Road N.E., Atlanta, GA 30329</aff>
<author-notes>
<corresp id="FN1"><label>*</label>Corresponding author: <email>brookersnyder@gmail.com</email>; <email>awchan@emory.edu</email></corresp>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>16</day>
<month>11</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="epub">
<day>10</day>
<month>11</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="ppub">
<month>3</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>01</day>
<month>3</month>
<year>2019</year>
</pub-date>
<volume>125</volume>
<issue>3</issue>
<fpage>401</fpage>
<lpage>417</lpage>
<!--elocation-id from pubmed: 10.1007/s00702-017-1803-y-->
<abstract>
<p id="P1">Huntington’s disease (HD) is a complex neurodegenerative disorder that has no cure. Although treatments can often be given to relieve symptoms, the neuropathology associated with HD cannot be stopped or reversed. HD is characterized by degeneration of the striatum and associated pathways that leads to impairment in motor and cognitive functions as well as psychiatric disturbances. Although cell and rodent models for HD exist, longitudinal study in a transgenic HD nonhuman primate (NHP; i.e. rhesus macaque; HD monkeys) shows high similarity in its progression with human patients. Progressive brain atrophy and changes in white matter integrity examined by magnetic resonance imaging (MRI) are coherent with the decline in cognitive behaviors related to corticostriatal functions and neuropathology. HD monkeys also express higher anxiety and irritability/aggression similar to human HD patients that other model systems have not yet replicated. While a comparative model approach is critical for advancing our understanding of HD pathogenesis, HD monkeys could provide a unique platform for preclinical studies and long-term assessment of translatable outcome measures. This review summarizes the progress in the development of the transgenic HD monkey model and the opportunities for advancing HD preclinical research.</p>
</abstract>
<kwd-group>
<kwd>Transgenic animal model</kwd>
<kwd>nonhuman primates</kwd>
<kwd>Huntington’s disease</kwd>
<kwd>comparative animal models</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>